Endothelial nitric oxide synthase uncoupling and microvascular dysfunction in the mesentery of mice deficient in α-galactosidase A.
A defect in the gene for the lysosomal enzyme α-galactosidase A (Gla) results in globotriaosylceramide (Gb3) accumulation in Fabry disease and leads to premature death from cardiac and cerebrovascular events. However, gastrointestinal symptoms are often first observed during childhood in these patients and are not well understood. In this study, we demonstrate an age-dependent microvasculopathy of the mesenteric artery (MA) in a murine model of Fabry disease (Gla-knockout mice) resulting from dysregulation of the vascular homeostatic enzyme endothelial nitric oxide synthase (eNOS). The progressive accumulation of Gb3 in the MA was confirmed by thin-layer chromatographic analysis. A total absence of endothelium-dependent dilation was observed in MAs from mice at 8 mo of age, while suppression of ACh-mediated vasodilation was evident from 2 mo of age. Endothelium-independent dilation with sodium nitroprusside was normal compared with age-matched wild-type mice. The microvascular defect in MAs from Fabry mice was endothelium-dependent and associated with suppression of the active homodimer of eNOS. Phosphorylation of eNOS at the major activation site (Ser(1179)) was significantly downregulated, while phosphorylation at the major inhibitory site (Thr(495)) was remarkably enhanced in MAs from aged Fabry mice. These profound alterations in eNOS bioavailability at 8 mo of age were observed in parallel with high levels of 3-nitrotyrosine, suggesting increased reactive oxygen species along with eNOS uncoupling in this vascular bed. Overall, the mesenteric microvessels in the setting of Fabry disease were observed to have an early and profound endothelial dysfunction associated with elevated reactive nitrogen species and decreased nitric oxide bioavailability.
Nephrology Division, Dept. of Internal Medicine, Univ. of Michigan, Box 5676, Rm. 1560 MSRB II, 1150 West Medical Center Dr., Ann Arbor, MI 48109-5676. jshayman@umich.edu.
Justin J
JJ
Kang
Liming
L
Shu
James L
JL
Park
James A
JA
Shayman
Peter F
PF
Bodary
D000109:Acetylcholine / Q000502:physiology; D000375:Aging / Q000502:physiology; D000818:Animals; D015153:Blotting, Western; D002196:Capillaries / Q000502:physiology; D000795:Fabry Disease / Q000201:enzymology / Q000235:genetics; D050356:Lipid Metabolism / Q000502:physiology; D008638:Mesenteric Arteries / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D020030:Nitric Oxide Donors / Q000494:pharmacology; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D009599:Nitroprusside / Q000494:pharmacology; D010641:Phenotype; D010766:Phosphorylation; D026361:Reactive Nitrogen Species / Q000378:metabolism; D013152:Splanchnic Circulation / Q000502:physiology*; D014281:Trihexosylceramides / Q000378:metabolism; D000519:alpha-Galactosidase / Q000235:genetics* / Q000502:physiology*
D020030:Nitric Oxide Donors; D026361:Reactive Nitrogen Species; D014281:Trihexosylceramides; D009599:Nitroprusside; C018549:globotriaosylceramide; D052250:Nitric Oxide Synthase Type III; D000519:alpha-Galactosidase; D000109:Acetylcholine
Fabry disease; glycosphingolipids; myograph; reactive nitrogen species; renal failure